daunorubicin has been researched along with nickel in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
AlegrÃa, AE; Santiago, G | 1 |
Chen, B; Guo, D; Hu, H; Li, X; Wang, X; Wu, C | 1 |
Awale, S; Balachandran, C; Bhuvanesh, NSP; Emi, N; Haribabu, J; Jeyalakshmi, K; Karvembu, R | 1 |
3 other study(ies) available for daunorubicin and nickel
Article | Year |
---|---|
Adriamycin and daunomycin semiquinone membrane/buffer partition constants using the spin-broadening technique.
Topics: Antibiotics, Antineoplastic; Cholesterol; Daunorubicin; Doxorubicin; Electron Spin Resonance Spectroscopy; Liposomes; Models, Chemical; Nickel; Oxidation-Reduction; Phosphatidylcholines; Quinones; Solubility; Xanthine Oxidase | 1997 |
Study on the enhanced cellular uptake effect of daunorubicin on leukemia cells mediated via functionalized nickel nanoparticles.
Topics: Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Daunorubicin; Electrochemistry; Humans; K562 Cells; Leukemia; Metal Nanoparticles; Microscopy, Atomic Force; Microscopy, Fluorescence; Nanotechnology; Nickel; Permeability; Tetrazolium Salts; Thiazoles | 2009 |
Nickel(II) bis(isatin thiosemicarbazone) complexes induced apoptosis through mitochondrial signaling pathway and G0/G1 cell cycle arrest in IM-9 cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cisplatin; Daunorubicin; Doxorubicin; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Nickel; Resting Phase, Cell Cycle; Signal Transduction; Thiosemicarbazones; U937 Cells | 2018 |